Mdm2-SNP309 polymorphism in prostate cancer: no evidence for association with increased risk or histopathological tumour characteristics.

Br J Cancer · 2008 · PMC2453021 · PMID 18577987

Europe PMC DOI

hedged sentence

0.2990

closest p · 6.0× alpha

0.2990

boldest claim

The sentences

did not reach statistical significanceP =0.299not close (p > 0.1)

Although there was a higher frequency of T/T genotypes in prostate cancer patients this difference did not reach statistical significance ( P =0.299, Table 2 , Figure 2 ).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.